The Anti-Tumorigenic Role of Cannabinoid Receptor 2 in Non-Melanoma Skin Cancer
Int J Mol Sci. 2023 Apr 24;24(9):7773. doi: 10.3390/ijms24097773. ABSTRACT Five million non-melanoma skin cancers occur globally each year, and it is one of the...
A Metabolomics and Big Data Approach to Cannabis Authenticity (Authentomics)
Int J Mol Sci. 2023 May 3;24(9):8202. doi: 10.3390/ijms24098202. ABSTRACT With the increasing accessibility of cannabis (Cannabis sativa L., also known as marijuana and hemp),...
Licensed Medical Cannabis Use in Gilles de la Tourette Syndrome: A Retrospective Long-term Follow-Up
Cannabis Cannabinoid Res. 2023 May 12. doi: 10.1089/can.2022.0281. Online ahead of print. ABSTRACT Background: Medical cannabis (MC) is widely used in clinical practice to treat...
Behavioral effects induced by the cannabidiol analogs HU-502 and HU-556
Behav Pharmacol. 2023 Jun 1;34(4):213-224. doi: 10.1097/FBP.0000000000000727. Epub 2023 May 10. ABSTRACT Cannabidiol is a phytocannabinoid that lacks the psychotomimetic properties of Δ9-tetrahydrocannabinol (THC), the...
A comparison of Echium, fish, palm, soya and linseed oil supplementation on pork quality
Anim Biosci. 2023 May 2. doi: 10.5713/ab.22.0362. Online ahead of print. ABSTRACT OBJECTIVE: Long chain n-3 PUFA exert positive effects on human health. The LC...
Cannabis and adverse cardiovascular events: A systematic review and meta-analysis of observational studies
Toxicol Rep. 2023 Apr 25;10:537-543. doi: 10.1016/j.toxrep.2023.04.011. eCollection 2023. ABSTRACT BACKGROUND: Cannabis is the most used illicit drug in the world. Global trends of decriminalization...
Cannabinoid Hyperemesis Syndrome and Hypophosphatemia in Adolescents
JPGN Rep. 2022 Sep 1;3(4):e248. doi: 10.1097/PG9.0000000000000248. eCollection 2022 Nov. ABSTRACT We report 3 adolescents with cannabis hyperemesis syndrome and recurrent hypophosphatemia complicating their clinical...
Persistent Diarrhea and Eosinophilic Esophagitis Resulting From Chronic Cannabidiol Usage for Refractory Epilepsy
JPGN Rep. 2022 Sep 30;3(4):e253. doi: 10.1097/PG9.0000000000000253. eCollection 2022 Nov. ABSTRACT Cannabidiol is used in the care of treatment-resistant epilepsy. It has been associated with...
A cross-sectional survey of prospective healthcare professionals’ knowledge, attitudes and perceptions of medical Cannabis
Explor Res Clin Soc Pharm. 2023 Apr 21;10:100275. doi: 10.1016/j.rcsop.2023.100275. eCollection 2023 Jun. ABSTRACT BACKGROUND: Compounds isolated from Cannabis possess many beneficial effects creating a...
Flavored cannabis use and cannabis-tobacco co-use: Use patterns is US states with legalized non-medical adult use
Am J Prev Med. 2023 May 9:S0749-3797(23)00208-8. doi: 10.1016/j.amepre.2023.05.006. Online ahead of print. ABSTRACT INTRODUCTION: Little is known about inhaled flavored cannabis use. This study...
Daring discourse: artificial intelligence in pain medicine, opportunities and challenges
Reg Anesth Pain Med. 2023 May 11:rapm-2023-104526. doi: 10.1136/rapm-2023-104526. Online ahead of print. ABSTRACT Artificial intelligence (AI) tools are currently expanding their influence within healthcare....
Maternal and infant cannabis testing and associated birth outcomes
Arch Gynecol Obstet. 2023 May 11. doi: 10.1007/s00404-023-07009-5. Online ahead of print. ABSTRACT OBJECTIVES: The objective of the study was to determine any identifiable clinical...
Associations of alcohol use disorder, cannabis use disorder, and nicotine dependence with concurrent opioid use disorder in U.S. adults
Exp Clin Psychopharmacol. 2023 May 11. doi: 10.1037/pha0000649. Online ahead of print. ABSTRACT Polysubstance use of alcohol, cannabis, and nicotine has been shown to be...
Adjunctive therapy with lipid-lowering agents in COVID-19: a systematic review and meta-analysis of randomized controlled trials
Lipids Health Dis. 2023 May 8;22(1):61. doi: 10.1186/s12944-023-01828-w. ABSTRACT BACKGROUND: Many commonly used drugs were evaluated as repurposed treatment options since the emergence of the...
Adjunctive therapy with lipid-lowering agents in COVID-19: a systematic review and meta-analysis of randomized controlled trials
Lipids Health Dis. 2023 May 8;22(1):61. doi: 10.1186/s12944-023-01828-w. ABSTRACT BACKGROUND: Many commonly used drugs were evaluated as repurposed treatment options since the emergence of the...